Hjem › Crohns sykdom › California › Lancaster
Kliniske studier for Crohns sykdom i Lancaster, CA
7 studier for Crohns sykdom søker deltakere på steder i og rundt Lancaster (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekruttererFase 2
- Gastro Care Institute /ID# 281071, Lancaster
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RekruttererFase 3
- Om Research LLC ( Site 5038), Lancaster
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 3
- Gastro Care Institute, Lancaster
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 2/3
- Om Research, LLC 1, Lancaster
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 3
- Om Research, LLC - Lancaster-Site Number: 8400148, Lancaster
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
RekruttererFase 2
- Gastro Care Institute, Lancaster
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
RekruttererFase 2
- Investigational Site Number: 8400001, Lancaster
Crohns sykdom-studier i andre byer
- New York City, NY35 studier
- Boston, MA19 studier
- Miami, FL19 studier
- Cleveland, OH19 studier
- St. Louis, MO19 studier
- Tyler, TX17 studier
- Houston, TX17 studier
- Orlando, FL17 studier
- Atlanta, GA17 studier
- San Antonio, TX15 studier
- San Diego, CA15 studier
- Los Angeles, CA15 studier
Andre studier i Lancaster
- Steatotisk leversykdom7 studier
- Ulcerøs kolitt7 studier
- Ikke-småcellet lungekreft4 studier
- Type 2-diabetes4 studier
- Astma4 studier
- Høyt blodtrykk3 studier
- Reaktivt tarmsyndrom3 studier
- Kardiovaskulær sykdom3 studier
- Inflammatorisk tarmsykdom3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.